Publicacións en colaboración con investigadores/as de Hospital Son Llàtzer (53)

2025

  1. Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study

    International Journal of Antimicrobial Agents, Vol. 66, Núm. 3

  2. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus

  3. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus, Vol. 34, Núm. 6, pp. 571-578

  4. Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: Insights from the ARTESER registry

    Rheumatology, Vol. 64, Núm. 9, pp. 4985-4994

  5. Gene-Specific Detection Rate of Adenomas and Advanced Adenomas in Lynch Syndrome

    Gastroenterology, Vol. 169, Núm. 4, pp. 663-675

  6. Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

    Arthritis Research and Therapy, Vol. 27, Núm. 1

  7. Perception and knowledge of CVD among women in Spain: national survey on awareness, risk, and lifestyle

    Revista Espanola de Cardiologia, Vol. 78, Núm. 11, pp. 1014-1017

  8. Resources and Readmission for COPD Exacerbation in Pneumology Units in Spain: The COPD Observatory Project

    Healthcare (Switzerland), Vol. 13, Núm. 3

  9. Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

    Seminars in Arthritis and Rheumatism, Vol. 74

2024

  1. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

    Lung Cancer, Vol. 194

  2. Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement — A Multicenter Cross-Sectional CLINI-AEDV Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 1, pp. 36-47

  3. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

  4. Multidisciplinary management of cardiovascular disease in women: Delphi consensus

    Frontiers in Cardiovascular Medicine, Vol. 11

  5. Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln GLA Variant in Anderson-Fabry Disease

    International journal of molecular sciences, Vol. 25, Núm. 8

2022

  1. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

  2. Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group

    Archivos de Bronconeumologia, Vol. 58, Núm. 11, pp. 776-779

  3. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  4. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*

    British Journal of Dermatology, Vol. 186, Núm. 1, pp. 142-152

  5. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  6. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

    Lung Cancer, Vol. 173, pp. 83-93